A detailed history of Aviva PLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Aviva PLC holds 8,281 shares of UTHR stock, worth $3.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,281
Previous 8,487 2.43%
Holding current value
$3.09 Million
Previous $2.7 Million 9.77%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$311.04 - $363.55 $64,074 - $74,891
-206 Reduced 2.43%
8,281 $2.97 Million
Q2 2024

Aug 02, 2024

BUY
$228.26 - $319.04 $1.33 Million - $1.86 Million
5,843 Added 220.99%
8,487 $2.7 Million
Q1 2024

May 14, 2024

BUY
$210.76 - $249.51 $13,277 - $15,719
63 Added 2.44%
2,644 $607,000
Q4 2023

Feb 09, 2024

SELL
$214.88 - $256.94 $3.88 Million - $4.64 Million
-18,044 Reduced 87.49%
2,581 $567,000
Q3 2023

Nov 13, 2023

BUY
$211.82 - $248.24 $4.37 Million - $5.12 Million
20,625 New
20,625 $4.66 Million
Q1 2023

May 12, 2023

BUY
$212.99 - $276.17 $16.9 Million - $21.9 Million
79,312 Added 677.71%
91,015 $20.4 Million
Q4 2022

Feb 09, 2023

SELL
$205.95 - $280.43 $657,186 - $894,852
-3,191 Reduced 21.42%
11,703 $3.25 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $433,232 - $520,326
-2,131 Reduced 12.52%
14,894 $3.12 Million
Q2 2022

Aug 04, 2022

BUY
$174.81 - $241.14 $2.98 Million - $4.11 Million
17,025 New
17,025 $4.01 Million
Q2 2021

Aug 10, 2021

SELL
$170.47 - $211.93 $1.24 Million - $1.54 Million
-7,249 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$153.94 - $174.85 $779,552 - $885,440
-5,064 Reduced 41.13%
7,249 $1.21 Million
Q4 2020

Feb 10, 2021

SELL
$101.87 - $151.79 $1.02 Million - $1.52 Million
-9,981 Reduced 44.77%
12,313 $1.87 Million
Q3 2020

Nov 12, 2020

BUY
$99.9 - $121.13 $325,074 - $394,157
3,254 Added 17.09%
22,294 $2.25 Million
Q2 2020

Aug 13, 2020

BUY
$92.74 - $125.82 $1.77 Million - $2.4 Million
19,040 New
19,040 $2.3 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.